Zunbo He
Hengyang, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 11 publications
Impact of sodium glucose cotransporter 2 inhibitors on bladder cancer and breast cancer: a pharmacovigilance analysis and Mendelian randomization study.
Journal: Expert opinion on drug safety
Published: November 24, 2025
Explore the potential mechanisms between ertugliflozin and kidney cancer through bioinformatics analysis and Mendelian randomization study.
Journal: International journal of surgery (London, England)
Published: August 07, 2025
Association between SGLT2 inhibitors and genital cancer: a meta-analysis and mendelian randomization study.
Journal: Journal of endocrinological investigation
Published: June 25, 2025
Mavorixafor: a CXCR4 antagonist for WHIM syndrome.
Journal: Immunopharmacology and immunotoxicology
Published: April 14, 2025
A comprehensive review of the efficacy and safety of ertugliflozin.
Journal: Expert opinion on drug metabolism & toxicology
Published: January 22, 2025
Investigating Sodium-Glucose Cotransporter 2 Inhibitors Versus Other Glucose-Lowering Drugs on Ventricular Arrhythmias or Sudden Cardiac Death Using the US FDA Adverse Event Reporting System.
Journal: Cardiovascular drugs and therapy
Published: November 14, 2024
Type II RAF inhibitor tovorafenib for the treatment of pediatric low-grade glioma.
Journal: Expert review of clinical pharmacology
Published: October 16, 2024
Association between sodium-glucose cotransporter 2 inhibitors and eye disorders: a systematic review and meta-analysis.
Journal: Expert review of clinical pharmacology
Published: August 29, 2024
Role of SLC5A2 polymorphisms and effects of genetic polymorphism on sodium glucose cotransporter 2 inhibitorsinhibitor response.
Journal: Molecular biology reports
Published: August 07, 2023
Effects of single-nucleotide polymorphism on the pharmacokinetics and pharmacodynamics of metformin.
Effects of single-nucleotide polymorphism on the pharmacokinetics and pharmacodynamics of metformin.
Journal: Expert review of clinical pharmacology
Published: September 06, 2022
CD25-targeted antibody-drug conjugate camidanlumab tesirine for relapsed or refractory classical Hodgkin lymphoma.
Journal: Investigational new drugs
Published: June 20, 2022
Showing 1-11 of 11
Last Updated: 09/26/2026